Walt Berghahn

Walt Berghahn is executive director of HCPC. He has been involved in the packaging industry for 30 years, with the last 20 years focused solely on pharmaceuticals.

Articles

ARTICLES

HCPC Column Main Image
HCPC Column

Moments of Reflection

Walt Berghahn
July 13, 2020
We all reach moments of reflection. An incident or series of events that makes you take a breath, step back and evaluate what has gone by and what might be to come. As a nation, we’ve had too many of these moments in the last few months.
Read More
HCPC Column Main Image
HCPC Column

Child-Resistance and Opioid Packaging

Walt Berghahn
December 18, 2019

While we wait for the FDA to compile and review the responses to its request for comments on Fixed Quantity Unit of Use Blisters Packaging, Docket No. FDA-2019-N-1845 in response to the SUPPORT Act of 2018, we want to take the safer packaging of opioids conversation a bit further.


Read More
HCPC Column Main Image
HCPC Column

Dr. Scott Gottlieb's Departure from FDA

Walt Berghahn
May 16, 2019

At this point in 2019 it is impossible not to give some well-deserved attention to the departure of Dr. Scott Gottlieb from the U.S. Food and Drug Administration (FDA). Anyone associated with pharmaceuticals or packaging was surprised at the announcement.


Read More
HCPC Column Main Image
HCPC Column

Unit Dose Packaging Gains Support

Unit Dose Packaging Gains Support Yet Leaves Package Open to Interpretation
Walt Berghahn
January 14, 2019
Anyone associated with pharmaceuticals and packaging is likely aware President Trump signed the SUPPORT Act recently. The Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as SUPPORT for Patients and Communities Act, includes a specific address to the type of packaging that should be utilized to stem the tide on opioid addiction.
Read More
HCPC Column Main Image
HCPC Column

Marijuana Packaging: Beyond the Bag

Walt Berghahn
November 9, 2018
From a packaging perspective, the legalization of marijuana — or more appropriately, taking it from prescription-only use to recreational — isn’t unusually complicated. Protect the product from moisture and oxygen. What about light? I’m not sure, but I guess there are those who will know.
Read More
HCPC Column Main Image
HCPC Column

FDA Favors Blister Packs In Battle Against Opioids

Benefits of unit-dose blister packaging include safeguarding medication efficacy, improved supply chain security and aiding medication adherence.
Walt Berghahn
March 15, 2018
In its most recent article, the HCPC reviewed how the FDA was looking at a variety of alternatives to stem the opioid epidemic. The HCPC has been involved in this effort by promoting the wide-ranging benefits of unit-dose blister packaging.
Read More

Keep the info flowing with our eNewsletters!

Get the latest industry updates tailored your way.

JOIN TODAY!